Hem / IKT -nav
Browsing Tag: IKT -nav
AALBORG EPAT SNABBGUIDE DAYLIGHT
--:--
Calculating...
Daylight Duration
🌅 Sunrise
--:--
🌇 Sunset
--:--
LATEST IKT -NAV NEWS
- Biotech Stocks At 52-Week Highs - ATTO, HALO, IKT, TVTX, ATRC
- Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Receives Average Recommendation of "Buy" from Brokerages
- Inhibikase Therapeutics (IKT) Slips 1.5% as Shares Test Support at $2.25 - Shakeout Pattern
- Inhibikase Therapeutics (IKT) Holds Steady at $2.41 as Shares Consolidate Between $2.29 Support and $2.53 Resistance - Reversal Setup Alerts
- IKT Q1 2026 Earnings: Narrower Loss of $0.10 Per Share Beats Estimates as Pre-Revenue Biotech Holds Steady - EPS Surprise History
